Kings Path Partners »

Ligand Pharmaceuticals In shares owned by Kings Path Partners

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $827k 8.3k 100.09
2024-06-30 $580k 6.9k 84.26

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Schwab Strategic Tr Us Tips Etf (SCHP)

View all positions for Kings Path Partners

Top funds holding Ligand Pharmaceuticals In

BlackRock
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
Dimensional Fund Advisors
State Street Corporation
Stephens Investment Management Group
Congress Asset Management
Chicago Capital
St. Denis J. Villere & Co
Geode Capital Management
Rice Hall James & Associates
Ashford Capital Management
Impax Asset Management Group

View all funds holding Ligand Pharmaceuticals In